Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of DVS-233 SR in Major Depressive Disorder
NCT00452595Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Jan 2004; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00452595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452595.